Table of Contents Author Guidelines Submit a Manuscript
Erratum

An erratum for this article has been published. To view the erratum, please click here.

BioMed Research International
Volume 2017, Article ID 5857369, 10 pages
https://doi.org/10.1155/2017/5857369
Research Article

The Feasibility of Xpert MTB/RIF Testing to Detect Rifampicin Resistance among Childhood Tuberculosis for Prevalence Surveys in Northern China

1Beijing Key Laboratory for Pediatric Diseases of Otolaryngology, Head and Neck Surgery, Beijing Pediatric Research Institute, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, China
2Key Laboratory of Major Diseases in Children, Ministry of Education, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, China
3Department 2 of Respiratory Medicine, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, China
4Department of Laboratory Medicine, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, China
5National Center for Tuberculosis Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China

Correspondence should be addressed to Shunying Zhao; moc.361@codgniynuhsoahz

Received 13 July 2017; Revised 17 October 2017; Accepted 9 November 2017; Published 5 December 2017

Academic Editor: Milton O. Moraes

Copyright © 2017 Jie Lu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. J. Dodd, C. Sismanidis, and J. A. Seddon, “Global burden of drug-resistant tuberculosis in children: a mathematical modelling study,” The Lancet Infectious Diseases, vol. 16, no. 10, pp. 1193–1201, 2016. View at Publisher · View at Google Scholar · View at Scopus
  2. C. M. Perez-Velez and B. J. Marais, “Tuberculosis in children,” The New England Journal of Medicine, vol. 367, no. 4, pp. 348–361, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. World Health Organization, Global Tuberculosis Report 2016, 2016.
  4. A. Wright, M. Zignol, A. Van Deun et al., “Epidemiology of antituberculosis drug resistance 2002-07: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance,” The Lancet, vol. 373, no. 9678, pp. 1861–1873, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. B. Williams, S. Ramroop, P. Shah et al., “Multidrug-resistant tuberculosis in UK children: Presentation, management and outcome,” European Respiratory Journal, vol. 41, no. 6, pp. 1456–1458, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Sandgren, L. E. Cuevas, M. Dara et al., “Childhood tuberculosis: Progress requires an advocacy strategy now,” European Respiratory Journal, vol. 40, no. 2, pp. 294–297, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. Y. Zhao, S. Xu, L. Wang et al., “National survey of drug-resistant tuberculosis in China,” The New England Journal of Medicine, vol. 366, no. 23, pp. 2161–2170, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. Y. Pang, Y. Wang, S. Zhao, J. Liu, Y. Zhao, and H. Li, “Evaluation of the Xpert MTB/RIF assay in gastric lavage aspirates for diagnosis of smear-negative childhood pulmonary tuberculosis,” The Pediatric Infectious Disease Journal, vol. 33, no. 10, pp. 1047–1051, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Tahseen, E. Qadeer, F. M. Khanzada et al., “Use of Xpert® MTB/RIF assay in the first national antituberculosis drug resistance survey in Pakistan,” The International Journal of Tuberculosis and Lung Disease, vol. 20, no. 4, pp. 448–455, 2016. View at Publisher · View at Google Scholar · View at Scopus
  10. World Health Organization, Guidelines for Surveillance of Drug Resistance in Tuberculosis, 5th edition, 2015.
  11. H. Li, J. Lu, J. Liu, Y. Zhao, X. Ni, and S. Zhao, “Linezolid is associated with improved early outcomes of childhood tuberculous meningitis,” The Pediatric Infectious Disease Journal, vol. 35, no. 6, pp. 607–610, 2016. View at Publisher · View at Google Scholar · View at Scopus
  12. “S. o. P. Subspecialty Group of Respiratory Diseases, Subspecialty Group, of Respiratory Diseases, Chinese Medical Association. Diagnostic standards and therapeutic recommendations for pulmonary tuberculosis in children,” Chinese journal of pediatrics, vol. 44, pp. 249–251, 2006.
  13. Y. Pang, H. Xia, Z. Zhang et al., “Multicenter evaluation of genechip for detection of multidrug-resistant mycobacterium tuberculosis,” Journal of Clinical Microbiology, vol. 51, no. 6, pp. 1707–1713, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. Y. Pang, Y. Zhou, B. Zhao et al., “Spoligotyping and drug resistance analysis of Mycobacterium Tuberculosis strains from national survey in China,” PLoS ONE, vol. 7, no. 3, Article ID e32976, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. Y. Pang, Q. Li, X. Ou et al., “Cost-Effectiveness Comparison of Genechip and Conventional Drug Susceptibility Test for Detecting Multidrug-Resistant Tuberculosis in China,” PLoS ONE, vol. 8, no. 7, Article ID e69267, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. X. Ou, H. Xia, Q. Li et al., “Cost analysis of Xpert Mtb/RIF test for the detection of M. tuberculosis and rifampin resistance,” Chinese Journal of Antituberculosis, vol. 35, pp. 723–728, 2013. View at Google Scholar
  17. M. P. Nicol, L. Workman, W. Isaacs et al., “Accuracy of the Xpert MTB/RIF test for the diagnosis of pulmonary tuberculosis in children admitted to hospital in Cape Town, South Africa: a descriptive study,” The Lancet Infectious Diseases, vol. 11, no. 11, pp. 819–824, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. C. C. Boehme, P. Nabeta, D. Hillemann et al., “Rapid molecular detection of tuberculosis and rifampin resistance,” The New England Journal of Medicine, vol. 363, no. 11, pp. 1005–1015, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. T. Wang, G.-D. Feng, Y. Pang et al., “High rate of drug resistance among tuberculous meningitis cases in Shaanxi province, China,” Scientific Reports, vol. 6, Article ID 25251, 2016. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Bates, J. O'Grady, M. Maeurer et al., “Assessment of the Xpert MTB/RIF assay for diagnosis of tuberculosis with gastric lavage aspirates in children in sub-Saharan Africa: a prospective descriptive study,” The Lancet Infectious Diseases, vol. 13, no. 1, pp. 36–42, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. G. Cheng, R. Tolhurst, R. Z. Li, Q. Y. Meng, and S. Tang, “Factors affecting delays in tuberculosis diagnosis in rural China: A case study in four counties in Shandong Province,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 99, no. 5, pp. 355–362, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. J. Banister, “Shortage of girls in China today,” Journal of Population Research, vol. 21, no. 1, pp. 19–45, 2004. View at Publisher · View at Google Scholar
  23. M. Prabhudas, B. Adkins, H. Gans et al., “Challenges in infant immunity: Implications for responses to infection and vaccines,” Nature Immunology, vol. 12, no. 3, pp. 189–194, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. Q.-Q. Yin, W.-W. Jiao, R. Han et al., “Rapid diagnosis of childhood pulmonary tuberculosis by Xpert MTB/RIF assay using bronchoalveolar lavage fluid,” BioMed Research International, vol. 2014, Article ID 310194, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. Y. Pang, J. Lu, Y. Wang, Y. Song, S. Wang, and Y. Zhao, “Study of the rifampin monoresistance mechanism in mycobacterium tuberculosis,” Antimicrobial Agents and Chemotherapy, vol. 57, no. 2, pp. 893–900, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. Q. Guo, Y. Pan, Z. Yang et al., “Epidemiology and clinical characteristics of pediatric drug-resistant tuberculosis in chongqing, China,” PLoS ONE, vol. 11, no. 3, Article ID 0151303, 2016. View at Publisher · View at Google Scholar · View at Scopus
  27. W. Jiao, Z. Liu, R. Han et al., “A country-wide study of spoligotype and drug characteristics of Mycobacterium tuberculosis from children in China,” PLoS ONE, vol. 8, no. 12, Article ID e84315, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. H. E. Jenkins, A. W. Tolman, C. M. Yuen et al., “Incidence of multidrug-resistant tuberculosis disease in children: systematic review and global estimates,” The Lancet, vol. 383, no. 9928, pp. 1572–1579, 2014. View at Publisher · View at Google Scholar · View at Scopus
  29. S. E. Dorman, V. N. Chihota, J. J. Lewis et al., “Performance characteristics of the cepheid Xpert MTB/RIF test in a tuberculosis prevalence survey,” PLoS ONE, vol. 7, no. 8, Article ID e43307, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. S. M. Graham, T. Ahmed, F. Amanullah et al., “Evaluation of tuberculosis diagnostics in children: 1. Proposed clinical case definitions for classification of intrathoracic tuberculosis disease. Consensus from an expert panel,” The Journal of Infectious Diseases, vol. 205, supplement 2, pp. S199–S208, 2012. View at Publisher · View at Google Scholar · View at Scopus